Josep-Maria Ribera - JoVE Visualize

Showing results (121-130 of 193) with videos related to

Pageof 20

Sort By:

British Journal of Haematology|June 26, 2014

Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow TransplantationLuciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, et al.

Journal of Hematology & Oncology|September 1, 2018

Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabineFederica Giannotti, Myriam Labopin, Roni Shouval, et al.

Haematologica|July 20, 2004

Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocolAlbert Oriol, Josep-Maria Ribera, Jordi Esteve, et al.

Leukemia & Lymphoma|April 29, 2016

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocolsCristina Motlló, Josep-Maria Ribera, Mireia Morgades, et al.

Blood Advances|June 8, 2022

Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaJosep-Maria Ribera, Olga García-Calduch, Jordi Ribera, et al.

European Journal of Haematology|November 27, 2019

Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutionsSantiago Mercadal, Juan-Manuel Sancho, Fina Climent, et al.

Haematologica|April 12, 2003

Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 studyAlbert Oriol, Josep-Maria Ribera, Jordi Esteve, et al.

Medicina Clinica|October 22, 2008

Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in SpainJuan-Manuel Sancho, Mireia Morgades, Natalia Alonso, et al.

Haematologica|October 14, 2011

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Carme Canals, Reyes Arranz, et al.

European Journal of Haematology|November 8, 2006

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemiaJuan-Manuel Sancho, Josep-Maria Ribera, Blanca Xicoy, et al.

Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:

Pageof 20

British Journal of Haematology|June 26, 2014

Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow TransplantationLuciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, et al.

Journal of Hematology & Oncology|September 1, 2018

Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabineFederica Giannotti, Myriam Labopin, Roni Shouval, et al.

Haematologica|July 20, 2004

Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocolAlbert Oriol, Josep-Maria Ribera, Jordi Esteve, et al.

Leukemia & Lymphoma|April 29, 2016

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocolsCristina Motlló, Josep-Maria Ribera, Mireia Morgades, et al.

Blood Advances|June 8, 2022

Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaJosep-Maria Ribera, Olga García-Calduch, Jordi Ribera, et al.

European Journal of Haematology|November 27, 2019

Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutionsSantiago Mercadal, Juan-Manuel Sancho, Fina Climent, et al.

Haematologica|April 12, 2003

Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 studyAlbert Oriol, Josep-Maria Ribera, Jordi Esteve, et al.

Medicina Clinica|October 22, 2008

Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in SpainJuan-Manuel Sancho, Mireia Morgades, Natalia Alonso, et al.

Haematologica|October 14, 2011

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Carme Canals, Reyes Arranz, et al.

European Journal of Haematology|November 8, 2006

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemiaJuan-Manuel Sancho, Josep-Maria Ribera, Blanca Xicoy, et al.

Pageof 20